Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support.

Authors:
Scot J Matkovich
Scot J Matkovich
Center for Pharmacogenomics
Keith A Youker
Keith A Youker
From the Methodist Diabetes and Metabolism Institute
Abhinav Diwan
Abhinav Diwan
Washington University School of Medicine
United States
William H Eschenbacher
William H Eschenbacher
Washington University School of Medicine
United States
Lisa E Dorn
Lisa E Dorn
Washington University
United States
Mark A Watson
Mark A Watson
Washington University School of Medicine
United States

Circulation 2009 Mar 23;119(9):1263-71. Epub 2009 Feb 23.

Center for Pharmacogenomics, Washington University, St Louis, MO 63110, USA.

Background: Much has been learned about transcriptional control of cardiac gene expression in clinical and experimental congestive heart failure (CHF), but less is known about dynamic regulation of microRNAs (miRs) in CHF and during CHF treatment. We performed comprehensive microarray profiling of miRs and messenger RNAs (mRNAs) in myocardial specimens from human CHF with (n=10) or without (n=17) biomechanical support from left ventricular assist devices in comparison to nonfailing hearts (n=11).

Methods And Results: Twenty-eight miRs were upregulated >2.0-fold (P<0.001) in CHF, with nearly complete normalization of the heart failure miR signature by left ventricular assist device treatment. In contrast, of 444 mRNAs that were altered by >1.3-fold in failing hearts, only 29 mRNAs normalized by as much as 25% in post-left ventricular assist device hearts. Unsupervised hierarchical clustering of upregulated miRs and mRNAs with nearest centroid analysis and leave-1-out cross-validation revealed that combining the miR and mRNA signatures increased the ability of RNA profiling to serve as a clinical biomarker of diagnostic group and functional class.

Conclusions: These results show that miRs are more sensitive than mRNAs to the acute functional status of end-stage heart failure, consistent with important functions for regulated miRs in the myocardial response to stress. Combined miR and mRNA profiling may have superior potential as a diagnostic and prognostic test in end-stage cardiomyopathy.

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.108.813576DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2749457PMC
March 2009
13 Reads

Publication Analysis

Top Keywords

heart failure
8
ventricular assist
8
biomechanical support
8
mir mrna
8
mirs
6
hearts unsupervised
4
hierarchical clustering
4
unsupervised hierarchical
4
device hearts
4
25% post-left
4
post-left ventricular
4
assist device
4
clustering upregulated
4
upregulated mirs
4
centroid analysis
4
analysis leave-1-out
4
leave-1-out cross-validation
4
nearest centroid
4
test end-stage
4
mirs mrnas
4

Altmetric Statistics

Similar Publications